Product Code: ETC8849421 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The post-acute myocardial infarction (AMI) market in the Philippines is witnessing growth due to the rising incidence of cardiovascular diseases. Post-AMI care involves medications, rehabilitation programs, and lifestyle modifications to prevent recurrence. Increasing awareness about heart disease management and government initiatives promoting cardiac care are supporting market expansion. However, limited access to specialized post-AMI care in rural areas may hinder market growth.
The post-acute myocardial infarction market in the Philippines is driven by the increasing incidence of heart attacks due to lifestyle-related risk factors such as hypertension, diabetes, and smoking. The growing emphasis on post-heart attack care, including medication, cardiac rehabilitation, and lifestyle modifications, is fueling demand for related treatments and services. Government-led healthcare programs and insurance coverage for cardiovascular disease management are also contributing to market expansion. Moreover, advancements in drug therapies and medical technologies aimed at improving post-myocardial infarction outcomes are further supporting market growth.
Challenges in the post-acute myocardial infarction market include limited access to advanced cardiac care facilities, particularly in rural areas of the Philippines. High treatment costs, including medications and rehabilitation programs, further restrict patient access. Moreover, a lack of awareness about the importance of long-term management after a heart attack contributes to poor patient adherence to treatment plans.
The increasing number of cardiac cases presents opportunities to invest in post-AMI rehabilitation centers, medication distribution, and telemedicine solutions for cardiac care. Investors can also explore digital health platforms offering remote monitoring and AI-driven risk assessment tools to improve patient outcomes. Collaborations with pharmaceutical companies to enhance access to post-AMI medications can be a profitable venture.
The Philippine Heart Association (PHA) and DOH implement heart disease prevention and treatment programs, influencing the post-AMI market. Policies under the Universal Health Care Act aim to improve access to post-AMI medications and rehabilitation services. PhilHealth provides partial coverage for heart disease treatments, but gaps in specialized cardiac care facilities, particularly in rural areas, may limit market growth.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Post Acute Myocardial Infarction Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Post Acute Myocardial Infarction Market - Industry Life Cycle |
3.4 Philippines Post Acute Myocardial Infarction Market - Porter's Five Forces |
3.5 Philippines Post Acute Myocardial Infarction Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Philippines Post Acute Myocardial Infarction Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 Philippines Post Acute Myocardial Infarction Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Post Acute Myocardial Infarction Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Post Acute Myocardial Infarction Market Trends |
6 Philippines Post Acute Myocardial Infarction Market, By Types |
6.1 Philippines Post Acute Myocardial Infarction Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Antiplatelet Therapy, 2021- 2031F |
6.1.4 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.2 Philippines Post Acute Myocardial Infarction Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Post Acute Myocardial Infarction Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.4 Philippines Post Acute Myocardial Infarction Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Philippines Post Acute Myocardial Infarction Market Import-Export Trade Statistics |
7.1 Philippines Post Acute Myocardial Infarction Market Export to Major Countries |
7.2 Philippines Post Acute Myocardial Infarction Market Imports from Major Countries |
8 Philippines Post Acute Myocardial Infarction Market Key Performance Indicators |
9 Philippines Post Acute Myocardial Infarction Market - Opportunity Assessment |
9.1 Philippines Post Acute Myocardial Infarction Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Philippines Post Acute Myocardial Infarction Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 Philippines Post Acute Myocardial Infarction Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Post Acute Myocardial Infarction Market - Competitive Landscape |
10.1 Philippines Post Acute Myocardial Infarction Market Revenue Share, By Companies, 2024 |
10.2 Philippines Post Acute Myocardial Infarction Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |